Patellofemoral pain syndrome (PFPS) is one of the most frequent diagnoses of knee pain^[@bibr9-1941738112441915]^ and has been reported to account for almost 10% of all visits to sports injury clinics.^[@bibr4-1941738112441915]^ Nonoperative treatment has classically been chosen as the initial form of intervention, although there is no clear choice for the most effective type of intervention, making treatment difficult.^[@bibr20-1941738112441915]^

Understanding the cause of injury for these patients can be challenging. Anterior or retropatellar knee pain is associated with functional impairments and disability, including diffuse knee pain, decreased quadriceps strength, and pain with activities such as stair climbing, prolonged sitting, squatting, kneeling, and running.^[@bibr15-1941738112441915]^ Proposed causes of this pain include patellofemoral malalignment; overuse; muscle or strength imbalances; osteochondral defects; and foot, ankle, hip, and pelvis biomechanical abnormalities.^[@bibr4-1941738112441915],[@bibr8-1941738112441915],[@bibr9-1941738112441915]^

Exercise therapy is commonly prescribed as a nonsurgical means to address deficits in muscular function in patients suffering from PFPS. Conservative exercise therapy tends to focus on improving the function of muscles controlling the patellofemoral and tibiofemoral joints, primarily increasing quadriceps and hip abductor strength.^[@bibr12-1941738112441915],[@bibr16-1941738112441915]^

Rest is also used to decrease knee pain symptoms. The goal is to eliminate activities that aggravate the patellofemoral joint.

Exercise and rest prescriptions may not address any of the etiologies that cause patellofemoral joint pain with activity. Since the exact cause of patellofemoral joint pain is often hard to diagnose, different treatment choices are likely to result in varied outcomes.

Pain is commonly measured by a visual analog scale (VAS), and physical function is often assessed by the Kujala Scoring Questionnaire: 13 items designed to assess knee function.^[@bibr10-1941738112441915]^ The VAS and Kujala Scoring Questionnaire are reliable measures of pain and function in patients with PFPS.^[@bibr2-1941738112441915]^

Methods {#section1-1941738112441915}
=======

Systematic searches were performed in September 2010 in 3 databases: PubMed (1966-present), CINAHL (1982-present), and SPORT Discus (1972-present). Keywords were *patellofemoral pain syndrome, patellofemoral pain syndrome treatment, patellofemoral pain and exercise, chondromalacia, anterior knee pain, efficacy of treatment, exercises, strengthening*. Combinations of these were used to be sure that all relevant articles were identified. Search limits included, if available in the search engine, human participants, studies reported in English, and clinical trials. Level I or II studies were included that reported means and standard deviations of VAS or Kujala scores as the primary outcome following an exercise/strengthening intervention in patients with PFPS. Studies were not included if they examined other interventions, such as bracing, taping, orthotics, or osteoarthritis. The search resulted in the acquisition of 125 initial studies. Ten studies were included after elimination of studies that were not Level I or II studies, did not use the Kujala Scoring Questionnaire or the VAS as an outcome measure, or did not report means and standard deviations ([Figure 1](#fig1-1941738112441915){ref-type="fig"}).

![Summary of search and selection process. PFPS = patellofemoral pain syndrome; VAS = visual analogue scale](10.1177_1941738112441915-fig1){#fig1-1941738112441915}

Study Quality Assessment {#section2-1941738112441915}
------------------------

The PEDro scale was used to assess the quality of the articles meeting the inclusion criteria. It was developed for the Physiotherapy Evidence Database by the Centre for Evidence-Based Physiotherapy; it includes a set of systematic questions designed to assess the internal validity and interpretability of the study,^[@bibr14-1941738112441915]^ as well as an 11-item checklist for study evaluation (maximum score of 10 points; the first criterion is not calculated in the total score).

Data Analysis {#section3-1941738112441915}
-------------

The effect sizes were calculated using the following formula:
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Weighted aggregate effect sizes and 95% confidence intervals were calculated for all studies reporting postintervention functional outcomes (Kujala scores) and pain ratings (VAS representing "usual" pain or pain at rest). Separate analyses were performed for outcomes measured immediately after the end of an intervention period and for outcomes measured at 3-month follow-up. Participant attrition (loss to follow-up) was accounted for in effect size calculations.

Results {#section4-1941738112441915}
=======

A total of 433 patients (297 women, 68.6%; 136 men, 31.4%) were analyzed with PFPS from 10 research articles ([Table 1](#table1-1941738112441915){ref-type="table"}).^[§](#fn1-1941738112441915){ref-type="fn"}^ Mean demographics were as follows: age, 29.13 ± 8.89 years; mass, 67.19 ± 11.09 kg; and height, 165.79 ± 245.18, cm.

###### 

Descriptions and critiques of reviewed studies.^[*a*](#table-fn1-1941738112441915){ref-type="table-fn"}^

  Study                                        Design                                               PEDRO   Critique
  -------------------------------------------- ---------------------------------------------------- ------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Van Linschoten^[@bibr19-1941738112441915]^   Open-label randomized controlled trial               7       Participants not randomized to group; participants, therapists, and assessors not blinded
  Crossley^[@bibr3-1941738112441915]^          Randomized double-blinded placebo-controlled trial   9       Therapist not blinded to group
  Loudon^[@bibr11-1941738112441915]^           Controlled clinical trial                            5       Participants not randomized to group; participants, therapists, and assessors not blinded; measures not obtained from ≥ 85% of original participants
  Song^[@bibr18-1941738112441915]^             Randomized controlled trial                          8       Participants not randomized to group; participants and therapists not blinded
  Alaca^[@bibr1-1941738112441915]^             Prospective cohort study                             3       No random assignment; allocation not concealed; participants, therapist, and assessor not blinded; no between-group comparisons
  Nakagawa^[@bibr13-1941738112441915]^         Randomized controlled pilot trial                    9       No blinded therapist
  Sacco^[@bibr17-1941738112441915]^            Pre- and posttest intervention cohort study          6       No random assignment; allocation not concealed; participants and therapist not blinded
  Witvrouw^[@bibr21-1941738112441915]^         Prospective randomized clinical trial, no control    5       Allocation not concealed; participants, therapist, and assessors not blinded; measures not obtained from 85% or more
  Ferber^[@bibr6-1941738112441915]^            Cohort study                                         4       No random assignment; allocation not concealed; participants, therapist, and assessors not blinded; groups not similar at baseline regarding the most important prognostic indicator
  Earl^[@bibr5-1941738112441915]^              Case series                                          3       No random assignment; allocation not concealed; participants, therapist, and assessors not blinded; groups not similar at baseline regarding the most important prognostic indicator; between-group statistical comparisons not used

Outcome at 3 months postintervention.

The analysis separated outcomes immediately after an exercise intervention and 3 months after. Five studies were clinical trials comparing an exercise intervention to a control group (1 sham was excluded; others were true controls); 4 compared 2 exercise interventions with no true control group; and 1 had no control group. Weighted effect sizes and 95% confidence intervals were determined ([Figures 2](#fig2-1941738112441915){ref-type="fig"} and [3](#fig3-1941738112441915){ref-type="fig"}).

![Pooled and weighted effect sizes with associated 95% confidence intervals for the changes in Kujala scores following exercise intervention (squares) and control interventions (circles). The top graphs represent outcomes reported immediately after the end of exercise intervention (solid circle and square), and the bottom part of the graph (outlined circle and square) shows outcomes measured 3 months following the intervention.](10.1177_1941738112441915-fig2){#fig2-1941738112441915}

![Pooled and weighted effect sizes with associated 95% confidence intervals for the changes in visual analog scale scores following exercise intervention (squares) and control interventions (circles). The top graphs represent outcomes reported immediately after the end of exercise intervention (solid circle and square), and the bottom part of the graph (outlined circle and square) shows outcomes measured 3 months following the intervention.](10.1177_1941738112441915-fig3){#fig3-1941738112441915}

Outcome data reported immediately following an exercise intervention were collected for PFPS in 200 patients (11 data sets in 8 articles) and for 52 following a control intervention (3 data sets from 3 articles). There was a loss to follow-up in 14 patients (8%) and 6 controls (17%). There was a very large effect for patient-reported functional outcomes (*d* = 2.19) and perceived pain (*d* = −1.24), which were larger than functional outcomes (*d* = 0.77) and pain (*d* = −0.14) in controls.

Short-term follow-up after exercise intervention for PFPS was reported in 191 patients from 4 data sets in 2 studies. A large effect for functional outcomes (*d* = 1.04) and pain (*d* = −0.82) was detected in patients who performed an exercise intervention. One study reported moderate effect sizes for functional outcomes (*d* = 0.59) and pain (*d* = −0.35) at 3 months postintervention.

Discussion {#section5-1941738112441915}
==========

These results indicate that exercise and rest both decrease pain and increase function in patients suffering from PFPS. However, the magnitude of effect for the improvements in pain and function in patients receiving exercise therapy were considerably higher and represent a favorable treatment for patients suffering from PFPS. While exercise is preferred to increase function and decrease pain, this review cannot detail the best exercise to perform ([Table 2](#table2-1941738112441915){ref-type="table"}). Exercise protocols were 3, 5, 6, or 8 weeks in duration. Single exercises, such as a leg press,^[@bibr8-1941738112441915]^ had significant improvement in pain and increased function (Lysholm scale scores), as did exercise prescriptions that included flexibility, strength, and muscle balance (quadriceps, adductor, and gluteals).^[@bibr1-1941738112441915],[@bibr3-1941738112441915],[@bibr11-1941738112441915],[@bibr13-1941738112441915],[@bibr17-1941738112441915],[@bibr19-1941738112441915],[@bibr21-1941738112441915]^ In studies comparing the effects of different exercise programs, no differences were found between the 2 exercise groups. Witrouv et al^[@bibr21-1941738112441915]^ compared open (n = 30) and closed kinetic chain (n = 30) exercise protocols and found that both statistically improved Kujala function scores and decreased perceived pain, although no statistical differences were found between the 2 groups. Only 1 study (group 1, n = 7; group 2, n = 7) found that exercise did not improve pain.^[@bibr1-1941738112441915],[@bibr3-1941738112441915],[@bibr11-1941738112441915]^ In this study, all participants performed general lower leg stretching with quadriceps strengthening, while the intervention group added strengthening of the transverse abdominis, hip abductors, and lateral rotator muscles. The effect size for the intervention group was small for usual pain (*d* = −0.27) but very large for worst pain (*d* = −1.40). The effect sizes for the control group were very large for usual (*d* = −1.29 and worst pain (*d* = −1.40). These results suggest that adding transverse abdominis, hip abductor, and lateral rotator muscles may improve pain outcomes in PFPS patients.

###### 

Treatment groups and effect size calculations for changes in pain ratings from baseline to postintervention.^[*a*](#table-fn2-1941738112441915){ref-type="table-fn"}^

  Study                                        Treatment Group 1                                                                                                                                                                     Treatment Group 2                                                                             Control Group                                                                                 Intervention, Weeks
  -------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ---------------------
  Van Linschoten^[@bibr19-1941738112441915]^   Quadriceps, hip adductor, and gluteal muscle strengthening (n = 65, *d* = −1.2)                                                                                                       N/A                                                                                           Daily isometric quadriceps contractions (n = 66, *d* = −0.62)                                 6
  Crossley^[@bibr3-1941738112441915]^          Patellar taping, vastus medialis obliquus biofeedback, gluteal muscle strengthening (n = 36, *d* = −3.5)                                                                              N/A                                                                                           Placebo tape, sham ultrasound (n = 35, *d* = −2.0)                                            6
  Loudon^[@bibr11-1941738112441915]^           Lower extremity muscle stretch/strengthen and patellar mobilizations (n = 9, *d* = −2.3)                                                                                              Home exercise program including stretching and strengthening (n = 9, *d* = −1.1)              True control: no exercise (n = 11, *d* = −0.27)                                               4
  Song^[@bibr18-1941738112441915]^             Leg press with external hip abduction force and quadriceps stretching (n = 27, *d* = −1.04)                                                                                           Leg press exercises (n = 27, *d* = −0.96)                                                     True control: no exercise (n = 25, *d* = −0.08)                                               8
  Witvrouw^[@bibr21-1941738112441915]^         Closed chain strengthening exercises (n = 30, *d* = −.87)                                                                                                                             Open kinetic chain strengthening exercises (n = 30, *d* = −0.80)                              No control group                                                                              5
  Sacco^[@bibr17-1941738112441915]^            Lower extremity muscle and iliotibial band stretching and squatting exercises (n = 6)                                                                                                 N/A                                                                                           True control: no exercise (n = 5)^[*b*](#table-fn3-1941738112441915){ref-type="table-fn"}^    5
  Nakagawa^[@bibr13-1941738112441915]^         Standard care, including muscle stretching and quadriceps strengthening with added hip abductor and lateral rotator muscles and transverse abdominis exercises (n = 7, *d* = −1.29)   Standard care including muscle stretching and quadriceps strengthening (n = 7, *d* = −0.27)   No control group                                                                              6
  Alaca^[@bibr1-1941738112441915]^             Lower extremity muscle and iliotibial band stretching and isokinetic knee extension exercises (n = 22, *d* = −1.77)                                                                   N/A                                                                                           No control group                                                                              6
  Ferber^[@bibr6-1941738112441915]^            Hip abductor strengthening (n = 10, *d* = −1.19)                                                                                                                                      N/A                                                                                           True control: no exercise (n = 10)^[*b*](#table-fn3-1941738112441915){ref-type="table-fn"}^   3
  Earl^[@bibr5-1941738112441915]^              Three-phase stability program: (1) hip and core muscle volitional control, (2) perturbation training, (3) patterned movement training (n = 19, *d* = −1.94)                           N/A                                                                                           No control group                                                                              8

N/A = not applicable (because the study did not have a second treatment group); n = number of participants; *d* = effect size for visual analog scale pain ratings from baseline to immediately following treatment. For ratings, negative effect sizes indicate reduced pain following treatment.

Controls did not have patellofemoral pain syndrome, so effect sizes are not calculated.

There were differences among the control groups used in the various studies included in this review. Many of the participants from these studies were not "true controls." Some control groups received placebo treatments, nonsteroidal anti-inflammatory drugs, or less rigorous forms of exercise for comparison with those in experimental intervention groups ([Table 2](#table2-1941738112441915){ref-type="table"}). The studies using "true controls"^[@bibr6-1941738112441915],[@bibr11-1941738112441915],[@bibr17-1941738112441915],[@bibr18-1941738112441915]^ had average effect sizes in Kujala and VAS outcomes of 0.23 and −0.29, whereas the average Kujala and VAS scores for patients in other control groups^[@bibr1-1941738112441915],[@bibr3-1941738112441915],[@bibr5-1941738112441915],[@bibr13-1941738112441915],[@bibr19-1941738112441915],[@bibr21-1941738112441915]^ were 0.8 and −1.18. This suggests that patients with PFPS will benefit from doing some exercise rather than nothing.

Two studies demonstrated large effect sizes for the no exercise group,^[@bibr3-1941738112441915],[@bibr10-1941738112441915]^ while 2 studies had small effect sizes indicating a positive treatment effect in control groups.^[@bibr5-1941738112441915],[@bibr8-1941738112441915]^ In review of these studies, larger treatment effects were reported in "controls" who were provided with some instructions or guidelines during the study period,^[@bibr10-1941738112441915]^ while smaller treatment effects for control groups were observed in studies^[@bibr5-1941738112441915],[@bibr8-1941738112441915]^ giving little information or suggestions for at-home treatment. Patient education---including activity recommendations, sham treatments,^[@bibr3-1941738112441915]^ low-intensity exercises,^[@bibr10-1941738112441915]^ and nonsteroidal anti-inflammatory drugs^[@bibr10-1941738112441915]^---have a role in improving patient outcomes. Participants in 1 study^[@bibr10-1941738112441915]^ were 2 to 3 times more likely than the exercise group to take nonsteroidal anti-inflammatory drugs. Improvements seen in PFPS patients treated with various interventions make it difficult to isolate the source of improvements.

Time also appears to influence recovery in PFPS patients when rest is compared to exercise. A 12-month follow-up of patients who had initially improved with exercise found no differences between the control and exercise groups.^[@bibr10-1941738112441915]^ In this review, there were much higher magnitude effect sizes immediately following the exercise/control interventions compared to the outcomes at 3 months ([Figure 1](#fig1-1941738112441915){ref-type="fig"}-[2](#fig2-1941738112441915){ref-type="fig"}). In patients that benefited from exercise interventions, once the rigorous guidance of supervised and/or home exercise programs stopped, patient outcomes clearly diminished.

There are several factors to consider when critically appraising research and when designing future research on PFPS. Few Level I clinical trials exist with ample effect sizes. There is a considerable lack of consistency regarding the content of control, experimental interventions, and patient-reported outcome instruments. Duration of treatments, follow-up time points, and use of the VAS vary among studies. Last, females tend to dominate the patient pool of most studies, and results are not separated by sex, thus compromising generalizability. However, since females tend to have higher incidences of PFPS,^[@bibr2-1941738112441915],[@bibr7-1941738112441915]^ this may be a fair representation of this sex bias.

In conclusion, exercise interventions for PFPS are effective for immediate decrease in pain and increase in function. However, these data suggest that improvements may not be maintained after short-term follow-up.
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